Intrinsic Value of S&P & Nasdaq Contact Us

VectivBio Holding AG VECT NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • CH • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$18.00
+6.7%

VectivBio Holding AG (VECT) — Analyst outlook / Analyst consensus target is. Based on 3 analyst ratings, the consensus is bullish — 3 Buy.

The consensus price target is $18.00, representing an upside of 6.7% from the current price $16.87.

VECT Stock — 12-Month Price Forecast

$18.00
▲ +6.70% Upside
Average Price Target
Based on 3 Wall Street analysts offering 12-month price targets for VectivBio Holding AG, the price target is $18.00.
The average price target represents a +6.70% change from the last price of $16.87.

VECT Analyst Ratings

Buy
3
Ratings
3 Buy
Based on 3 analysts giving stock ratings to VectivBio Holding AG in the past 3 months
Rating breakdown
Buy
3 100%
100%
Buy
3 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message